Morphosys AG - ADR

-0.17 (-1.04%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.10B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$41.23 Million
Adjusted EPS-$0.59
See more estimates
10-Day MA$17.01
50-Day MA$19.69
200-Day MA$24.50
See more pivots

Morphosys AG - ADR Stock, NASDAQ:MOR

Semmelweisstrasse 7, Semmelweisstrasse 7, Planegg, Bayern (Bavaria) 82152
Phone: +49.89.89927.0
Number of Employees: 615


MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.